MedPath

Intra- and Inter-evaluator Reproducibility of Upper Limb Strength Measures in Patients With COPD

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Other: pulmonary rehabilitation
Registration Number
NCT04341753
Lead Sponsor
University Hospital, Brest
Brief Summary

According to the recommendations of French and international learned societies, respiratory rehabilitation is part of the care of patients with Chronic Obstructive Pulmonary Disease (COPD). Indeed, scientific work carried out for more than 10 years on the respiratory rehabilitation of patients suffering from COPD shows that respiratory rehabilitation allows a reduction of the handicap caused by the disease and an improvement in the quality of life of the patients.

A respiratory rehabilitation program (PRR) includes: individual exercise re-training, therapeutic education, respiratory physiotherapy, help with smoking cessation and nutritional and psychosocial care. Exercise retraining includes training the muscles of the lower limbs in endurance and strength combined with training the muscles of the upper limbs. Strengthening the upper limbs helps reduce dyspnea in patients with COPD. In order to determine a precise muscle building protocol, it is necessary to assess at the start of the program the maximum voluntary strength (FMV) of the different muscle groups of the upper limbs. Measuring FMV quantifies a possible frequent strength deficit in patients with COPD and the effects of the strengthening program. Currently, tests to assess FMV using isokinetic dynamometers are used as a benchmark. However, this material is little used in current practice. Portable dynamometers are used to perform simple tests and to obtain muscle strength measurements. However, the reliability of the maximum voluntary force measurements of the different muscle groups of the upper limb has not been evaluated. Studies seem necessary to determine the reproducibility of the measurement in intra and inter-examiner (Schrama 2014) and to assess its sensitivity to change during a respiratory rehabilitation program. The objectives of this study are to study the reproducibility, validity and sensitivity to change of the measurement of FMV using a portable dynamometer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • Patient with COPD stages 2 to 4 (A to D) admitted to the pulmonary rehabilitation unit of Centre Hospitalier des Pays de Morlaix (4 weeks)
  • Patient able to consent and having signed a consent form
  • Patient 18 years of age or older
Exclusion Criteria
  • Patient with pain, arthritis, prosthetics, shoulder or elbow surgery.
  • Patient with a history of pneumonectomy, lobectomy less than 6 months old
  • Refusal to participate
  • Patient with an inability to follow a full respiratory rehabilitation program
  • Patient under guardianship or curatorship

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pulmonary rehabilitationpulmonary rehabilitationIn addition to the usual evaluation, other tests will be carried out in addition and specifically for this study: * the strength' measure of the deltoids, triceps and brachial biceps will be carried out by another technique: the 1-RM technique (with dumbbells); * 2 other times, the strength' measure of the deltoids, triceps and brachial biceps will be carried out by handheld dynaometry.
Primary Outcome Measures
NameTimeMethod
Change isometric voluntary muscle strength measure, with hand held dynamometerup to 4 weeks

the strength of the deltoid, biceps, triceps muscles is measured with handheld dynamometer, 3 times

Secondary Outcome Measures
NameTimeMethod
The dyspnea sensation by LCADL questionnaireup to 4 weeks

he improvement in dyspnea sensation is measured with the LCADL questionnaire The purpose of this questionnaire is to help understand how the patient perceives and feels your breathing with a score from 0 to 75

isometric voluntary muscle strength measure, with hand held dynamometer4 weeks

the strength of the deltoid, biceps, triceps muscles is measured with handheld dynamometer, a te the beginning and and the end of the pulmonary rehabilitation program

1-minute sit to stand testup to 4 weeks

The improvement in exercise capacity is measured during a 1-minute sit to stand test

Quality of life by CAT questionnaireup to 4 weeks

The improvement in quality of life is measured with CAT questionnaire. The CAT is one component in clinical decision-making, along with other considerations such as history of previous exacerbations and airflow limitation. A score is calculated from 8 questions with an answer from 0 to 5.

The dyspnea sensation by Modified Medical Research Council scaleup to 4 weeks

The improvement in dyspnea sensation is measured with the Modified Medical Research Council scale This unidimensional scale is used to assess dyspnea in the daily life of a patient from stage 0 to stage 4.

isometric voluntary muscle strength measure, with the one repetition of maximal resistance (1-MR) test (with dumbbells)up to 4 weeks

the strength of the deltoid, biceps, triceps muscles is measured with 1-MR test

the 6-minute walk testup to 4 weeks

The improvement in exercise capacity is measured in the 6-minute walk test

The voluntary force of the quadricepsup to 4 weeks

the maximum voluntary force of the quadriceps is measured with a MICROFET dynamometer

he endurance time of quadricepsup to 4 weeks

the improvement of the endurance time of quadriceps is mesured with a MICROFET dynamometer

the dyspnea sensation by dypsnea-12 scaleup to 4 weeks

The improvement in dyspnea sensation is measured with the dypsnea-12 scale. This questionnaire is used to evaluate the physical and emotional aspects of dyspnea with 12 questions.

Quality of life by St Georges questionnaireup to 4 weeks

The improvement in quality of life is measured with St Georges questionnaire This questionnaire is a self-reported disease-specific, health-related quality of life questionnaire. It was originally developed to measure the impact of Chronic Obstructive Pulmonary Disease on a person's life, but has also been studied and applied to non-COPD pulmonary populations.

Fear of fallingup to 4 weeks

The decrease in fear of falling is measured with the FES-I questionnaire. This questionnaire evaluates the fear of falling with a score from 0 to 30.

Self-esteemup to 4 weeks

The changes in self-esteem are measured with ISP-6 questionnaire This questionnaire is a 6-question questionnaire on overall self-esteem giving a score of

the dyspnea sensation by MDP questionnaireup to 4 weeks

The improvement in dyspnea sensation is measured with the MDP questionnaire This questionnaire makes it possible to measure the discomfort, the sensory qualities of the dyspnea, the intensity of the sensations, the emotional sensations.

Anxiety and depressionup to 4 weeks

The evolution of anxiety and depression is measured with HAD scale This scale is an instrument for screening for anxiety and depressive disorders. It consists of 14 items rated from 0 to 3. Seven questions are related to the anxiety dimension (total A) and seven others to the depressive dimension (total D), allowing two scores to be obtained (maximum score of each score = 21).

Evolution of the non fat mass indexup to 4 weeks

The evolution of the non fat mass index is measured with impedancemetry

Trial Locations

Locations (1)

Centre Hospitalier des pays de Morlaix

🇫🇷

Morlaix, France

© Copyright 2025. All Rights Reserved by MedPath